Saturday 1 August 2015

‘Mental health suffers most in major nuclear accidents’

People caught up in a nuclear disaster are more likely to suffer severe psychological disorders such as depression and post-traumatic stress disorder rather than any harm from radiation, scientists said on Friday. Factors such as having to evacuate homes or simply fear contribute


Ebola vaccine proves fully effective in Guinea trial

The world is for the first time on the verge of being able to protect humans against Ebola, the World Health Organization (WHO) said on Friday, as data from a trial in Guinea showed a vaccine was 100 per cent effective. Initial results from the trial, which tested Merck and NewLi


Aster Medcity wins JCI accreditation

Aster Medcity, a leading healthcare destination in India, has won the Gold Seal of Approval from the Joint Commission International (JCI) for exceptional standards in healthcare and patient safety. Known as the gold standard in global healthcare, the JCI Accreditation was awarded


Gene variation identified for teen binge eating

A variation of a gene that can lead teenagers to binge eat has been identified by a team from the UCL Institute of Child Health, the research partner of Great Ormond Street Hospital. The researchers hope the finding will allow a better understanding of why binge eating develops,


GSK plans staged roll-out of malaria vaccine

The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday. "We believe that there should be a thoughtful, staged roll-out of this vaccine, particularly because


Zulekha unveils fleet of buggies for patients

The Zulekha Hospital in Dubai and Sharjah has introduced a fleet of chauffeur-driven buggies to carry patients and visitors inside for appointments from the car park. It is part of the new meet and greet services at the hospital, said a statement. Zanubia Shams, ch


Hikma to acquire Roxane for $2.65bn

Hikma Pharmaceuticals, a leading multinational pharmaceutical group, is set to acquire Roxane Laboratories and Boehringer Ingelheim Roxane, from Boehringer Ingelheim. The acquisition has an aggregate value of gross consideration of about $2.65 billion, sad a statement.


Teva to take over Allergan generic business for $40.5bn

Teva Pharmaceutical Industries will pay $40.5 billion in cash and stock for Allergan’s generic drugs business, solidifying Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs, paying down debt and potential “transformationa


S Korea declares country out of Mers danger

South Korea declared on Tuesday it is effectively out of danger from Middle East Respiratory Syndrome (Mers), more than two months after the first case was reported and began spreading in hospital settings to kill 36 people. The outbreak grew to become the largest outside Saudi A


Plea to increase staff at Bahrain’s main hospital

A shortage of staff at Bahrain’s main hospital during weekends and public holidays is causing unnecessary suffering to sickle cell anaemia patients, an activist has claimed. Bahrain Society for Sickle Cell Anaemia Patient Care president Zakreya Al Kadhem said that sickle ce

 1 2 3 > 

calendarCalendar of Events